Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-2-17
pubmed:abstractText
G protein-coupled receptors (GPCRs) can assume multiple conformations and possess multiple binding sites. Whereas endogenous agonists acting at the orthosteric binding site stabilize the active receptor conformation, small molecules that act at nonorthosteric sites can stabilize alternative conformations. The large majority of these allosteric modulators associate with extracellular loops of GPCRs. The role of intracellular domains in mediating allosteric modulation is largely unknown. In screening a small-molecule library for inhibitors of platelet activation, we identified a family of compounds that modified PAR1-mediated granule secretion. The most potent inhibitory compound, termed JF5, also demonstrated noncompetitive inhibition of the ?(2A)-adrenergic receptor. Aggregation studies using a battery of platelet GPCR agonists demonstrated that sensitivity to JF5 was limited to GPCRs that possessed a constrained eighth helix, as defined by a C-terminal palmitoylation site and interactions with TM7 and the i1 loop. Inhibition by JF5 was overcome in a PAR1 mutant in which the eighth helix was deleted, confirming a role for helix 8 in JF5 activity. Evaluation of downstream signaling showed that JF5 was selective with regard to G protein coupling, blocking signaling mediated by G(?q) but not G(?12). The compound inhibited thrombus formation in vivo following vascular injury with an IC(50) of ?1 mg/kg. These results indicate a role for helix 8 in conferring sensitivity to small molecules, and show that this sensitivity can be exploited to control platelet activation during thrombus formation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-11127873, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-11805322, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-12023272, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-12601165, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-12837380, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-14645013, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-16354660, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-16402041, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-16507775, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-16835302, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-17009927, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-17190826, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-18042736, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-18676678, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-19286091, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-19395672, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-19458711, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-20025243, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-20233217, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-2865672, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-6116620, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-7935012, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-9716134, http://linkedlifedata.com/resource/pubmed/commentcorrection/21282664-9862790
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2951-6
pubmed:dateRevised
2011-8-25
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1.
pubmed:affiliation
Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural